Rasmussen’s encephalitis
Not for Routine Use
When screening requests for approval, the following information may be taken into account as there is some evidence for IG to be considered as an option.
Order Number: N17-RE
| Recommendations | IVIG is an option as a short-term, temporizing measure for patients with Rasmussen’s encephalitis. Not recommended for long-term therapy. |
| Dose/Frequency of Administration | Adults: Total dose of 2 g/kg divided over 2 to 5 days. Pediatric: Total dose of 2 g/kg divided over 2 days. |